AzTrials
AzTrials

Nursing CareNCT05469035

The Effect of Nurse Training on the Improvement of Subcutaneous Heparin Applications

A study testing Mobile-based video and Face-to-face in people with Nursing Care, run by Istanbul Saglik Bilimleri University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

One of the most important duties and responsibilities of nurses is drug administration. During drug administration, the nurse uses appropriate administration techniques and ensures patient safety by knowing the drugs and their side effects. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Nursing Care
What is being tested?
Mobile-based video and Face-to-face
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
No sites listed yet
Study dates
15 Jul 2022to 30 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • volunteering to participate in the study

Who cannot join

  • not have administered subcutaneous heparin in the clinical practice

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Hamidiye Faculty of Nursing, University of Health Sciences

One of the most important duties and responsibilities of nurses is drug administration. During drug administration, the nurse uses appropriate administration techniques and ensures patient safety by knowing the drugs and their side effects. This study aimed to examine the effect of nurse training on the improvement of subcutaneous heparin applications. In this study, it was planned to train nurses by using two different training methods. These methods are online and face-to-face training.

In both methods, it was planned to evaluate the subcutaneous drug administration knowledge and skill of nurses before and after the training.

Read the detailed description

Drug administration is a common nursing clinical intervention. The nurse ensures patient safety by using compatible administration techniques and being aware of the side effects of medications. Pharmacological agents such as heparins, vaccines, insulin, hormone drugs, etc., are generally inappropriate with oral, intravenous or intamuscular intake. Thereupon, they have to be administered by means of subcutaneous (SC) injection. Subcutaneous medications are injected into the tissue layer between the skin and the muscle that is called subcutaneous tissue where does not have a rich blood supply. Suitable areas for subcutaneous injction application are the lateral aspect of the upper arms, posterior aspect of the upper arms, anterior surface of the thigh, unders the scapulas and abdomen in the umbilical region. For the reason that abdominal region has an excess subcutaneous fat tissue, enough space for repeated injections and less muscle activity, it is highly preferred for subcutaneous injections. The angle of entry of the needle into the tissue depends on the needle length and the thickness of the subcutaneous tissue mass. A 90-degree angle is used if the subcutaneous tissue thicknes is about 5 cm. However, when it is 2.5 cm the angle of a 45-degree angle is recommended. To check whether the needle tip is in the vein or not during the application causes the needle movement in the tissue that then results in vascular damage, bleeding, ecchymosis and hematoma formation. Airlock technique in subcutaneous inections is recommended as it ensures that the entire drug is delivered to the tissue as well as preventing the escape of the drug.

Conditions
Nursing Care
Being tested
Mobile-based video, Face-to-face
Keywords
Subcutaneous heparin injections, nursing, training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobile-based videoOther

    Also called SC Heparin Interventions

    Nurses in the experimental group participated in mobile-based video learning.

  • Face-to-faceOther

    Also called SC Heparin Interventions

    Nurses in the experimental group participated in face-to-face learning.

Study groups in NCT05469035
Study groupRoleWhat they receive
ExperimentalExperimentalNurses in the experimental group participated in mobile-based video learning.
Receives: Other: Mobile-based video
ControlActive comparatorNurses in the experimental group participated in face-to-face learning.
Receives: Other: Face-to-face

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improvement of subcutaneous heparin applications

    The primary outcome of this study is the improvement of nurses' subcutaneous heparin applications. The 25-item checklist prepared by the researchers based on the literature includes the application steps of subcutaneous heparin knowledge and skill.

    Measured: Through study completion, an average of 1 months

Secondary outcomes (1)
  1. Comparision of two different method

    The secondary outcome of this study is the comparison of the two different education methods.The 25-item checklist prepared by the researchers based on the literature includes the application steps of subcutaneous heparin knowledge and skill.

    Measured: Through study completion, an average of 1 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2022
  2. Study start15 Jul 2022 (estimated)
  3. Primary completion10 Aug 2022 (estimated)
  4. Study completion30 Aug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
A randomized controlled, pre-post-test, mixed-method
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05469035
Sponsor's protocol ID
1640
Status last verified
Jul 2022
First submitted
30 Jun 2022
Last updated
21 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hegland PA, Aarlie H, Stromme H, Jamtvedt G. Simulation-based training for nurses: Systematic review and meta-analysis. Nurse Educ Today. 2017 Jul;54:6-20. doi: 10.1016/j.nedt.2017.04.004. Epub 2017 Apr 19.

    PubMed 28456053
  • Demir R, Inangil D, Turkoglu I, Sendir M. Improving subcutaneous injection safety among nurses: a randomized controlled trial of video-based and face-to-face training. BMC Nurs. 2026 Jan 6;25(1):119. doi: 10.1186/s12912-025-04281-5.

    PubMed 41495726

Questions about this trial

What is this clinical trial studying?

A study testing Mobile-based video and Face-to-face in people with Nursing Care, run by Istanbul Saglik Bilimleri University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Demet İnangil (05303021160, demet.inangil@sbu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improvement of subcutaneous heparin applications (time frame: Through study completion, an average of 1 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05469035, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in